Menu

• Ask a Health Expert about BRONCHOALVEOLAR LAVAGE ABNORMAL
• Post Your Side Effect related to BRONCHOALVEOLAR LAVAGE ABNORMAL
• BRONCHOALVEOLAR LAVAGE ABNORMAL and FDA Warnings
• BRONCHOALVEOLAR LAVAGE ABNORMAL in Patients Wiki
• Report BRONCHOALVEOLAR LAVAGE ABNORMAL in Drug Side Effect Survey

BRONCHOALVEOLAR LAVAGE ABNORMAL side effect

What is BRONCHOALVEOLAR LAVAGE ABNORMAL ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Cyclosporine Side Effects Report #5669302-5
Consumer or non-health professional from JAPAN reported CYCLOSPORINE problem on Mar 07, 2008. Female patient, 39 years of age, was diagnosed with prophylaxis against graft versus host disease and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: bronchoalveolar lavage abnormal, chest x-ray abnormal, mechanical ventilation, pulmonary alveolar haemorrhage, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with RITUXAN, FLUDARABINE PHOSPHATE, METHOTREXATE, IRRADIATION. Patient recovered.

Propofol Side Effects Report #5550573-0
PROPOFOL problem was reported by a Physician from UNITED STATES on Nov 26, 2007. Female patient, 49 years of age, was diagnosed with intubation and was treated with PROPOFOL. After drug was administered, patient experienced the following problems/side effects: bronchoalveolar lavage abnormal, lung infiltration, lung injury, . PROPOFOL dosage: 4MG/KG/H. Patient was hospitalized. Patient recovered.

Cubicin Side Effects Report #5397130-7
Physician from UNITED STATES reported CUBICIN problem on July 10, 2007. Male patient, 87 years of age, weighting 176.4 lb, was diagnosed with osteomyelitis chronic and was treated with CUBICIN. After drug was administered, patient experienced the following problems/side effects: bronchoalveolar lavage abnormal, chest pain, ejection fraction decreased, eosinophilic pneumonia chronic, left ventricular dysfunction, lung consolidation, pleural effusion, pulmonary eosinophilia, . CUBICIN dosage: 4.4 MG/KG; Q24H; IV. During the same period patient was treated with BACTRIM, CEFTRIAXONE, AZITHROMYCIN, LEVOFLOXACIN, LISINOPRIL, FERROUS SULPHATE, COREG, LASIX. Patient was hospitalized. Patient recovered.

Cubicin Side Effects Report #5397130-7
CUBICIN problem was reported by a Physician from UNITED STATES on July 10, 2007. Male patient, 87 years of age, weighting 176.4 lb, was diagnosed with osteomyelitis chronic and was treated with CUBICIN. After drug was administered, patient experienced the following problems/side effects: bronchoalveolar lavage abnormal, chest pain, ejection fraction decreased, eosinophilic pneumonia chronic, left ventricular dysfunction, lung consolidation, pleural effusion, pulmonary eosinophilia, . CUBICIN dosage: 4.4 MG/KG; Q24H; IV. During the same period patient was treated with BACTRIM, CEFTRIAXONE, AZITHROMYCIN, LEVOFLOXACIN, LISINOPRIL, FERROUS SULPHATE, COREG, LASIX. Patient was hospitalized. Patient recovered.


Alimta Side Effects Report #5712920-6
Consumer or non-health professional from UNITED STATES reported ALIMTA problem on Apr 21, 2008. Male patient, weighting 163.1 lb, was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: bronchoalveolar lavage abnormal, fungal infection, interstitial lung disease, . ALIMTA dosage: 955 MG. Patient was hospitalized. Patient died on 04/15/2008.

Tegretol Side Effects Report #5650657-2
TEGRETOL problem was reported by a Physician from JAPAN on Feb 25, 2008. Male patient, 82 years of age, weighting 119.0 lb, was diagnosed with convulsion, reflux oesophagitis, emphysema and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: bronchiectasis, bronchoalveolar lavage abnormal, c-reactive protein increased, dyspepsia, dyspnoea exertional, emphysema, hiatus hernia, interstitial lung disease, pneumonia, . TEGRETOL dosage: 200 MG, BID. During the same period patient was treated with LANSOPRAZOLE, CLARITHROMYCIN. Patient was hospitalized. Patient recovered.

Tegretol Side Effects Report #5631822-7
Physician from JAPAN reported TEGRETOL problem on Feb 12, 2008. Male patient, 82 years of age, weighting 119.0 lb, was diagnosed with convulsion, reflux oesophagitis, emphysema and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: bronchiectasis, bronchoalveolar lavage abnormal, c-reactive protein increased, dyspepsia, dyspnoea exertional, emphysema, hiatus hernia, interstitial lung disease, pneumonia, . TEGRETOL dosage: 200 MG, BID. During the same period patient was treated with LANSOPRAZOLE, CLARITHROMYCIN. Patient was hospitalized. Patient recovered.

Temozolomide Side Effects Report #5509868-9
TEMOZOLOMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 07, 2007. Male patient, weighting 213.5 lb, was treated with TEMOZOLOMIDE. After drug was administered, patient experienced the following problems/side effects: asthenia, bronchoalveolar lavage abnormal, cytomegalovirus infection, incorrect dose administered, platelet count abnormal, tricuspid valve incompetence, white blood cell count abnormal, . TEMOZOLOMIDE dosage: 8200 MG. Patient was hospitalized. Patient recovered.

Prednisone Side Effects Report #5512362-2
Health Professional from INDIA reported PREDNISONE problem on Oct 22, 2007. Male patient, 64 years of age, was diagnosed with angioedema, bronchospasm, eosinophilia, urticaria and was treated with PREDNISONE. After drug was administered, patient experienced the following problems/side effects: blood culture positive, bronchoalveolar lavage abnormal, confusional state, escherichia infection, hypotension, multi-organ failure, sepsis, strongyloidiasis, . PREDNISONE dosage: 30 MG QD PO. During the same period patient was treated with ORAPRED, OMEPRAZOLE. Patient died.


Thymoglobulin Side Effects Report #5489004-8
THYMOGLOBULIN problem was reported by a Health Professional from FRANCE on Sept 21, 2007. Female patient, 62 years of age, weighting 119.0 lb, was diagnosed with liver transplant, immunosuppression and was treated with THYMOGLOBULIN. After drug was administered, patient experienced the following problems/side effects: ascites, bronchoalveolar lavage abnormal, bronchopulmonary aspergillosis, cholestasis, condition aggravated, cytomegalovirus infection, . THYMOGLOBULIN dosage: 1.5 MG/KG QOD IV. During the same period patient was treated with PROGRAF, METHYLPREDNISOLONE, ULCAR, ACUPAN, UMULINE, LEVOPHED, AUGMENTIN, TRIFLUCAN. Patient was hospitalized. Patient died.

Lescol Side Effects Report #5702155-5
Consumer or non-health professional from FRANCE reported LESCOL problem on Apr 03, 2008. Male patient, 72 years of age, was treated with LESCOL. After drug was administered, patient experienced the following problems/side effects: antineutrophil cytoplasmic antibody positive, bronchoalveolar lavage abnormal, chest pain, chest x-ray abnormal, cough, dyspnoea, glomerular filtration rate decreased, interstitial lung disease, . LESCOL dosage: 80 MG, QD. During the same period patient was treated with CELECTOL, ZANIDIP, PLAVIX, ALLOPURINOL, COKENZEN, LASILIX. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5714458-9
VELCADE problem was reported by a Physician from JAPAN on Apr 09, 2008. Male patient, 73 years of age, weighting 116.8 lb, was diagnosed with multiple myeloma, prophylaxis, pneumonia bacterial and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: brain natriuretic peptide increased, bronchoalveolar lavage abnormal, disease progression, dizziness, fungal infection, inappropriate antidiuretic hormone secretion, interstitial lung disease, orthostatic hypotension, pneumonia bacterial, . VELCADE dosage: 1.60 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, MEIACT, BAKTAR, ITRACONAZOLE, DECADRON, RABEPRAZOLE, AMLODIPINE BESYLATE, BASEN. Patient died on 04/09/2008.

Ludiomil Side Effects Report #5289325-8
Consumer or non-health professional from JAPAN reported LUDIOMIL problem on Mar 28, 2007. Female patient, 77 years of age, weighting 112.4 lb, was diagnosed with depression, thirst and was treated with LUDIOMIL. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, bronchoalveolar lavage abnormal, c-reactive protein increased, cell marker increased, chest x-ray abnormal, fatigue, interstitial lung disease, lung infiltration, oxygen saturation decreased, . LUDIOMIL dosage: 75 MG/D. During the same period patient was treated with TSUMURA BYAKKOKANINJINTO, AMOBAN, TECIPUL. Patient was hospitalized. Patient recovered.

Ludiomil Side Effects Report #5274087-0
LUDIOMIL problem was reported by a Consumer or non-health professional from JAPAN on Mar 12, 2007. Female patient, 77 years of age, was diagnosed with depression and was treated with LUDIOMIL. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, bronchoalveolar lavage abnormal, c-reactive protein increased, cell marker increased, chest x-ray abnormal, lung infiltration, pneumonitis, white blood cell count increased, . LUDIOMIL dosage: unknown. Patient recovered.


Clofarabine Side Effects Report #5664303-5
Health Professional from UNITED STATES reported CLOFARABINE problem on Feb 28, 2008. Female patient, 70 years of age, weighting 200.2 lb, was diagnosed with acute myeloid leukaemia and was treated with CLOFARABINE. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, blood lactate dehydrogenase increased, bronchoalveolar lavage abnormal, candidiasis, enterococcal sepsis, febrile neutropenia, hypertension, lipase increased, pneumonia, . CLOFARABINE dosage: 38 MG, QDX5, INTRAVENOUS; 0, QDX5, INTRAVENOUS. During the same period patient was treated with TIGECYCLINE, DIFLUCAN, VANCOMYCIN, VORINCONAZOLE, AZITHROMYCIN. Patient was hospitalized. Patient recovered.

Methylprednisolo Side Effects Report #5541940-X
METHYLPREDNISOLONE problem was reported by a Consumer or non-health professional from BELGIUM on Nov 23, 2007. Male patient, 52 years of age, was diagnosed with renal and pancreas transplant and was treated with METHYLPREDNISOLONE. After drug was administered, patient experienced the following problems/side effects: atelectasis, bronchial disorder, bronchoalveolar lavage abnormal, bronchopulmonary aspergillosis, cardiac failure, cardiac murmur, enterobacter infection, enterococcal infection, fungal endocarditis, . METHYLPREDNISOLONE dosage: 500 MG, INTRAVENOUS; 40 MG, QD; 6 MG,QD, ORAL. During the same period patient was treated with MYCOPHENOLATE MOFETIL, SIMULECT, TACROLIMUS. Patient was hospitalized. Patient died.

Prednisone Side Effects Report #5526176-0
Physician from DENMARK reported PREDNISONE problem on Nov 05, 2007. Female patient, 75 years of age, was diagnosed with lung abscess and was treated with PREDNISONE. After drug was administered, patient experienced the following problems/side effects: alpha haemolytic streptococcal infection, asthenia, bronchoalveolar lavage abnormal, ill-defined disorder, lung abscess, micrococcus infection, . PREDNISONE dosage: unknown. During the same period patient was treated with METHOTREXATE, ORAPRED. Patient died.

Prednisolone Side Effects Report #5416642-0
PREDNISOLONE problem was reported by a Physician from DENMARK on July 30, 2007. Female patient, 26 years of age, was diagnosed with prophylaxis and was treated with PREDNISOLONE. After drug was administered, patient experienced the following problems/side effects: alpha haemolytic streptococcal infection, blood culture positive, bronchoalveolar lavage abnormal, candidiasis, cardiac valve vegetation, endocarditis, intracardiac mass, leukopenia, lung infiltration, . PREDNISOLONE dosage: unknown. During the same period patient was treated with TACROLIMUS, ORAPRED, VALGANCICLOVIR. Patient was hospitalized. Patient recovered.

Humira Side Effects Report #5743046-3
Physician from SOUTH AFRICA reported HUMIRA problem on May 09, 2008. Female patient, weighting 123.5 lb, was diagnosed with rheumatoid arthritis and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: bacterial sepsis, biopsy lung abnormal, bronchoalveolar lavage abnormal, candidiasis, candiduria, immune reconstitution syndrome, infectious disease carrier, . HUMIRA dosage: unknown. During the same period patient was treated with METHOTREXATE, METHYLPREDNISOLONE, FOLIC ACID, OMEPRAZOLE, CELECOXIB. Patient was hospitalized. Patient recovered.


Humira Side Effects Report #5754542-7
HUMIRA problem was reported by a Physician from SOUTH AFRICA on May 09, 2008. Female patient, weighting 123.5 lb, was diagnosed with rheumatoid arthritis and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: bacterial sepsis, biopsy lung abnormal, bronchoalveolar lavage abnormal, candidiasis, candiduria, immune reconstitution syndrome, infectious disease carrier, . HUMIRA dosage: unknown. During the same period patient was treated with METHOTREXATE, METHYLPREDNISOLONE, FOLIC ACID, OMEPRAZOLE, CELECOXIB. Patient was hospitalized. Patient recovered.

Prograf Side Effects Report #5319882-4
Physician from UNITED STATES reported PROGRAF problem on Apr 18, 2007. Female patient, 19 years of age, was diagnosed with lung transplant rejection and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: arthritis bacterial, bacterial infection, bronchoalveolar lavage abnormal, cellulitis, complications of transplanted lung, culture positive, culture urine positive, endophthalmitis, fungaemia, . PROGRAF dosage: unknown. During the same period patient was treated with PREDNISONE, VORICONAZOLE, TRIMETOPRIM, VALGANCICLOVIR. Patient died.

Wypax Side Effects Report #5328417-1
WYPAX problem was reported by a Physician from JAPAN on Apr 26, 2007. Female patient, 22 years of age, was treated with WYPAX. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, blood pressure decreased, bronchoalveolar lavage abnormal, lung disorder, somnolence, systemic inflammatory response syndrome, wheezing, . WYPAX dosage: 96 MG 1X ORAL. During the same period patient was treated with AMOXAN, VALPROATE, OLANZAPINE, ETHYL LOFLAZEPATE, ETIZOLAM, ANAFRANIL. Patient was hospitalized. Patient recovered.